InvestorsHub Logo
Followers 29
Posts 5387
Boards Moderated 0
Alias Born 11/21/2019

Re: dimelander post# 2151

Friday, 03/04/2022 8:54:27 AM

Friday, March 04, 2022 8:54:27 AM

Post# of 3504
$STAB is currently in the third and final Central Institutional Review Board approved phase of their clinical trials for the treatment of pediatric Chrohn’s disease. Its previous trials showed a lot of promise.